科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/10/13 | 4,420 | 4,430 | 4,385 | 4,420 | +40 | +0.9% | 94,900 |
| 2021/10/12 | 4,475 | 4,490 | 4,380 | 4,380 | -120 | -2.7% | 72,900 |
| 2021/10/11 | 4,485 | 4,515 | 4,475 | 4,500 | ±0 | ±0% | 57,100 |
| 2021/10/08 | 4,495 | 4,545 | 4,485 | 4,500 | +5 | +0.1% | 88,200 |
| 2021/10/07 | 4,530 | 4,550 | 4,490 | 4,495 | -35 | -0.8% | 101,300 |
| 2021/10/06 | 4,450 | 4,545 | 4,445 | 4,530 | +60 | +1.3% | 96,200 |
| 2021/10/05 | 4,550 | 4,555 | 4,460 | 4,470 | -105 | -2.3% | 133,800 |
| 2021/10/04 | 4,565 | 4,580 | 4,525 | 4,575 | +65 | +1.4% | 78,600 |
| 2021/10/01 | 4,595 | 4,615 | 4,510 | 4,510 | -85 | -1.8% | 90,800 |
| 2021/09/30 | 4,600 | 4,650 | 4,575 | 4,595 | +35 | +0.8% | 98,300 |
| 2021/09/29 | 4,600 | 4,600 | 4,510 | 4,560 | -125 | -2.7% | 198,200 |
| 2021/09/28 | 4,735 | 4,735 | 4,675 | 4,685 | -70 | -1.5% | 127,400 |
| 2021/09/27 | 4,850 | 4,850 | 4,755 | 4,755 | -95 | -2% | 153,800 |
| 2021/09/24 | 4,845 | 4,880 | 4,830 | 4,850 | +60 | +1.3% | 103,300 |
| 2021/09/22 | 4,830 | 4,855 | 4,790 | 4,790 | -25 | -0.5% | 159,800 |
| 2021/09/21 | 4,870 | 4,870 | 4,815 | 4,815 | -60 | -1.2% | 103,100 |
| 2021/09/17 | 4,890 | 4,920 | 4,850 | 4,875 | -15 | -0.3% | 321,500 |
| 2021/09/16 | 4,890 | 4,895 | 4,845 | 4,890 | +5 | +0.1% | 145,500 |
| 2021/09/15 | 4,930 | 4,955 | 4,885 | 4,885 | -110 | -2.2% | 146,000 |
| 2021/09/14 | 4,990 | 5,010 | 4,950 | 4,995 | ±0 | ±0% | 87,700 |
| 2021/09/13 | 4,970 | 4,995 | 4,935 | 4,995 | -45 | -0.9% | 112,800 |
| 2021/09/10 | 5,010 | 5,040 | 5,000 | 5,040 | +10 | +0.2% | 124,200 |
| 2021/09/09 | 5,050 | 5,080 | 5,010 | 5,030 | -40 | -0.8% | 69,000 |
| 2021/09/08 | 5,130 | 5,130 | 5,050 | 5,070 | -80 | -1.6% | 142,400 |
| 2021/09/07 | 5,200 | 5,240 | 5,130 | 5,150 | +30 | +0.6% | 101,500 |
| 2021/09/06 | 5,110 | 5,140 | 5,090 | 5,120 | +60 | +1.2% | 75,800 |
| 2021/09/03 | 5,000 | 5,100 | 5,000 | 5,060 | +50 | +1% | 112,200 |
| 2021/09/02 | 5,040 | 5,050 | 4,995 | 5,010 | -60 | -1.2% | 75,600 |
| 2021/09/01 | 4,995 | 5,080 | 4,975 | 5,070 | +100 | +2% | 87,100 |
| 2021/08/31 | 4,970 | 5,010 | 4,920 | 4,970 | -40 | -0.8% | 187,300 |
| 2021/08/30 | 5,000 | 5,020 | 4,980 | 5,010 | +20 | +0.4% | 119,900 |
| 2021/08/27 | 5,050 | 5,070 | 4,960 | 4,990 | -70 | -1.4% | 129,900 |
| 2021/08/26 | 5,070 | 5,100 | 5,050 | 5,060 | -70 | -1.4% | 90,200 |
| 2021/08/25 | 5,180 | 5,180 | 5,080 | 5,130 | -100 | -1.9% | 88,400 |
| 2021/08/24 | 5,290 | 5,330 | 5,200 | 5,230 | -20 | -0.4% | 76,800 |
| 2021/08/23 | 5,200 | 5,300 | 5,200 | 5,250 | +80 | +1.5% | 106,600 |
| 2021/08/20 | 5,140 | 5,200 | 5,140 | 5,170 | +40 | +0.8% | 85,000 |
| 2021/08/19 | 5,030 | 5,140 | 5,030 | 5,130 | +130 | +2.6% | 120,600 |
| 2021/08/18 | 4,975 | 5,040 | 4,975 | 5,000 | +5 | +0.1% | 104,200 |
| 2021/08/17 | 4,965 | 5,020 | 4,965 | 4,995 | ±0 | ±0% | 61,800 |
| 2021/08/16 | 5,020 | 5,030 | 4,960 | 4,995 | -25 | -0.5% | 68,200 |
| 2021/08/13 | 4,975 | 5,040 | 4,970 | 5,020 | +80 | +1.6% | 103,700 |
| 2021/08/12 | 4,960 | 4,980 | 4,925 | 4,940 | -10 | -0.2% | 68,300 |
| 2021/08/11 | 4,925 | 4,960 | 4,905 | 4,950 | +15 | +0.3% | 77,900 |
| 2021/08/10 | 4,880 | 4,950 | 4,875 | 4,935 | +50 | +1% | 72,900 |
| 2021/08/06 | 4,870 | 4,900 | 4,850 | 4,885 | +15 | +0.3% | 54,600 |
| 2021/08/05 | 4,850 | 4,935 | 4,850 | 4,870 | -15 | -0.3% | 72,400 |
| 2021/08/04 | 4,885 | 4,950 | 4,870 | 4,885 | ±0 | ±0% | 99,000 |
| 2021/08/03 | 4,925 | 4,955 | 4,845 | 4,885 | -85 | -1.7% | 134,400 |
| 2021/08/02 | 4,900 | 4,970 | 4,895 | 4,970 | +135 | +2.8% | 118,300 |
901～
950
件表示中 / 3723件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 383,600円 | -6.4% | -71.8% | 4.95% | 42.84倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 371,000円 | +21.7% | +999.9% | 0.00% | 15.55倍 | 5.14倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 295,200円 | +7.9% | -3.3% | 2.71% | 8.21倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 201,800円 | +3.1% | -6.5% | 2.38% | 9.36倍 | 0.99倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
